Parikh, P MGupta, SDawood, SRugo, HBhattacharyya, G SAgarwal, AChacko, RSahoo, T PBabu, GAgarwal, SMunshi, AGoswami, CSmruti, B KBondarde, SDesai, CRajappa, SSomani, NSingh, MNimmagadda, RPavitran, KMehta, AParmar, VDesai, SNair, RDoval, D2014-12-292014-12-292014-01Parikh P M, Gupta S, Dawood S, Rugo H, Bhattacharyya G S, Agarwal A, Chacko R, Sahoo T P, Babu G, Agarwal S, Munshi A, Goswami C, Smruti B K, Bondarde S, Desai C, Rajappa S, Somani N, Singh M, Nimmagadda R, Pavitran K, Mehta A, Parmar V, Desai S, Nair R, Doval D. ICON 2013: Practical consensus recommendations for hormone receptor-positive Her2-negative advanced or metastatic breastcancer. Indian Journal of Cancer. 2014 Jan-Mar; 51(1): 73-79.http://imsear.searo.who.int/handle/123456789/154291The management of hormone receptor‑positive Her2‑negative breast cancer patients with advanced or metastatic disease is a common problem in India and other countries in this region. This expert group used data from published literature, practical experience, and opinion of a large group of academic oncologists, to arrive at practical consensus recommendations for use by the community oncologists.enChemotherapydeveloping countriesendocrine therapyguidelineswomenBreast Neoplasms --metabolismBreast Neoplasms --secondaryBreast Neoplasms --therapyCombined Modality TherapyConsensusDisease ManagementFemaleHumansPractice Guidelines as TopicReceptors, ErbB-2 --metabolismReceptors, Estrogen --metabolismReceptors, Progesterone --metabolismSocieties, MedicalArticle